Bioreperia is a start-up service company that develops new products for accelerating drug discovery and improving the diagnosis of cancer patients. Our first product speeds up drug efficacy assessment by early ”proof-of-concept” studies in toxicology, oncology, and for personalized cancer medicine using xenograft zebrafish models. This is in line with the overall aim of Bioreperia to minimize suffering and mortality from cancer and other diseases.